GPH基因技术在治疗非淋等泌尿生殖感染中的应用  

An analysis of the application of GPH gene technology in the treatment of urogenital infections such as non-gonococcal urethritis

作　　者：许鸣[1] 薛晏 叶淑芬[1] 王家薇 李久海 

机构地区：[1]哈尔滨市疾病预防控制中心,黑龙江哈尔滨150056 [2]黑龙江省生殖保健服务中心,黑龙江哈尔滨150020

出　　处：《中国医药科学》2014年第8期144-146,共3页China Medicine And Pharmacy

摘　　要：目的：探讨GPH基因技术在治疗非淋等泌尿生殖感染中的临床效果。方法选择2012年8月~2013年10月哈尔滨市223例性病就诊者进行治疗，其中非淋菌性尿道炎91例，淋病64例,尖锐湿疣38列，生殖器疱疹，24例，软下疳6例，均有非婚性接触史。结果经过长达4～6个月的跟踪随访，治愈率为98.21%。结论GPH基因技术在治疗非淋等泌尿生殖感染方面取得了显著效果，充分显示出GPH基因技术所具有的疗效显著、治疗安全、不易复发的突出优势。Objective To explore the clinical effect of GPH gene technology in the treatment of urogenital infections such as non-gonococcal urethritis. Methods 223 patients with sexually transmitted diseases who were treated in Harbin from August 2012 to October 2013 were selected, among whom 91 patients were diagnosed as non-gonococcal urethritis,64 gonorrhea,38 condyloma acuminatum,24 genital herpes and 6 chancroid.They all had unmarried sexual contact. Results The recovery rate was 98.21% during follow-ups up to 4-6 months. Conclusion The GPH gene technology achieves significant effect in the treatment of urogenital infections such as non-gonococcal urethritis,which proves its outstanding advantages of significant curative effect,safe treatment and being uneasy to relapse.

关 键 词：GPH基因技术 治疗 非淋菌性尿道炎 泌尿生殖感染 

分 类 号：R446[医药卫生—诊断学]